UCB is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology - UCB focuses on securing a leading position in severe disease categories.
As a leader in the Biopharma industry, we offer our people a challenging environment made of passion, integrity and accountability resulting in exceptional opportunities for discovery and contribution. With a unique combination of expertise in biology and chemistry, UCB is a global biopharma.
UCB Pharma, dedicated to Diversity inclusion, Diversity Hiring and Diversity Jobs.
no jobs found
| New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures |